ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
3,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
4,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
5,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
6,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
7,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,2,Immobile,Disability issues,Lifestyle issues,SocCi,N
8,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
9,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
10,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
11,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
12,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
13,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
14,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
15,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
16,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
17,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
18,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
19,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
20,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
20,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
21,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,2,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
21,3,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
21,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
21,5,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
22,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
23,2,Claustrophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
23,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
24,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
24,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
24,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
24,4,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
24,5,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
25,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
25,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
25,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
25,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
25,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
26,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
27,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
27,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
27,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
28,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
29,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
30,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
30,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
30,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
32,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
32,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
33,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
34,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
35,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
35,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
35,3,CREST syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
35,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
35,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
35,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
35,7,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
35,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
35,9,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
35,10,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
36,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
36,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
36,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
38,1,Dyspnoea at rest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
38,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,Y
38,4,Pulmonary artery dilatation,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
38,5,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
39,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
40,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
40,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
40,3,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
41,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
42,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
42,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
42,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
42,4,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
42,5,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
42,6,Sclerodactylia,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,7,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
43,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
43,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
44,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
44,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
44,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
44,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
44,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
45,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
45,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
45,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
46,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
46,2,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
46,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
47,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
48,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
48,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
49,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
50,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
50,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
51,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
51,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
51,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
51,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
51,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
52,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
52,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
52,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
52,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
53,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,2,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
53,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
54,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
54,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
54,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
55,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
56,1,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
57,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
58,1,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
58,2,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
59,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
60,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
61,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
62,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
62,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
62,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
63,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
64,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,3,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
65,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
65,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
65,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
65,4,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
65,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,7,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
65,8,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
65,9,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
65,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
65,11,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
65,12,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
65,13,Respiratory alkalosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
65,14,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
65,15,Venous pressure jugular increased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
65,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,1,Cardioversion,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
66,2,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
66,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
66,4,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
66,5,Resuscitation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
66,6,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
67,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
68,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
69,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
70,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
70,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
71,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
71,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
71,3,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
71,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
71,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
72,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
72,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
72,3,Blood bilirubin abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
72,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
72,5,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
72,6,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
72,7,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
72,8,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
72,9,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
73,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
74,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
75,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
75,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,Y
76,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
76,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
77,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
77,2,Endocarditis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
77,3,Endotracheal intubation,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
78,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
78,2,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
78,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
79,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
79,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
79,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
80,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
80,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
80,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
80,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
80,5,Sinus headache,Headaches NEC,Headaches,Nerv,N
80,6,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
81,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
81,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
81,3,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
82,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
82,3,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
83,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
84,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
85,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
85,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
86,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
87,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
87,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
88,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
88,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
89,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
90,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
91,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
91,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
91,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,6,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
91,7,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
91,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
91,9,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
92,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
93,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
93,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,4,Biopsy liver,Hepatobiliary histopathology procedures,Hepatobiliary investigations,Inv,N
93,5,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
93,6,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
93,7,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
93,8,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
93,9,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,10,Non-alcoholic steatohepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
93,11,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
93,12,Waist circumference increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
94,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
95,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
96,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
97,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
97,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
97,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
97,4,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
97,5,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
98,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
98,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
98,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
98,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
99,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
99,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
99,3,Brain natriuretic peptide increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
99,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
99,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
99,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
100,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
100,2,Jejunostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
100,3,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
100,4,Oesophagogastric fundoplasty,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
100,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
101,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
102,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
103,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
103,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
104,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
105,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
106,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
106,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
107,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
108,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
109,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
109,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
109,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
110,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
111,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
112,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
113,1,Heart transplant,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
114,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
114,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
114,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
115,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
116,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
116,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
117,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
118,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
119,1,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
119,2,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
119,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
120,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
121,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
122,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
123,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
124,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
124,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
125,1,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
125,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
125,3,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
125,4,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
125,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
126,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
126,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
127,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
128,1,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
128,2,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
128,3,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
128,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
129,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
130,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
130,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
131,1,Lung transplant,Bronchial and pulmonary therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
131,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
134,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,1,Heart and lung transplant,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
135,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
135,3,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
136,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
137,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
137,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
138,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
138,2,Right-to-left cardiac shunt,Cardiovascular disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
139,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
139,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
140,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
141,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
141,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
141,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
142,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
142,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
142,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
143,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
144,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
145,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
146,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
146,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
146,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
147,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
148,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
149,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
150,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
150,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
